Graduated in Biomedicine from Universidade Paulista (2017), where completed her degree with thesis on evaluation of the use of monoclonal antibodies in oncological therapy. Completed the professional development program in Immunogenetics at HC-FMRP-USP, working in the Immunogenetics laboratory at the Hemocentro de Ribeirão Preto (2018). Master of Science (2021) from the Department of Genetics at the Faculty of Medicine of Ribeirão Preto-FMRP/USP, when worked with genetic etiologies for hereditary endometrial cancer. Currently a PhD student at the Department of Genetics at the Faculty of Medicine of Ribeirão Preto-FMRP / USP working with cellular metabolism in pediatric Medulloblastoma. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Medulloblastoma (MB) is the most common pediatric malignant tumor of the central nervous system (CNS), representing approximately 20% of CNS tumors in children and adolescents. For these patients, the five-year overall survival (OS) is 40 to 90%, with variations between the molecular subgroups of MB (SHH, WNT, Group 3 and 4), among which Group 3 and SHH with TP53-mutated represent the mos…
Medulloblastoma (MB) represents ~20% of all pediatric central nervous system malignancies. Group 3 tumors are considered the most aggressive forms of MB and are associated with the worst prognosis. Group 3 tumors also display increased metabolic activity, which is induced by malignant transformation to promote tumor cells' survival. Under conditions of cellular stress in the tumor microen…
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID